This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Merck Hdac Research, LLC, Sloan-Kettering Institute for Cancer Research. Active years: 2010-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 12 
2 out of 519 
Years Active: 2010-2011
Title: Innovations by William Kevin Kelly
Introduction
William Kevin Kelly is an accomplished inventor based in Scotch Plains, NJ (US). He holds two patents that focus on innovative methods for treating various forms of cancer, particularly Hodgkin's and non-Hodgkin's lymphoma. His work has significantly contributed to the field of oncology, providing new avenues for effective treatment.
Latest Patents
Kelly's latest patents include methods of treating Hodgkin's and non-Hodgkin's lymphoma. The present invention provides methods of selectively inducing terminal differentiation, cell growth arrest, and/or apoptosis of neoplastic cells. It also involves inhibiting histone deacetylase (HDAC) through the administration of pharmaceutical compositions that comprise potent HDAC inhibitors. The oral bioavailability of the active compounds in these pharmaceutical compositions is surprisingly high. Moreover, these compositions unexpectedly yield high, therapeutically effective blood levels of the active compounds over an extended period. The invention further outlines a safe, daily dosing regimen that is easy to follow, resulting in a therapeutically effective amount of HDAC inhibitors in vivo. Additionally, he has developed methods of treating cancer that share similar innovative approaches and benefits.
Career Highlights
Throughout his career, Kelly has worked with notable organizations such as Merck HDAC Research and the Sloan-Kettering Institute for Cancer Research. His contributions in these roles have been instrumental in advancing cancer research and treatment methodologies.
Collaborations
Some of his notable coworkers include Victoria M. Richon and Judy H. Chiao. Their collaborative efforts have further enriched the research environment and fostered innovation in cancer treatment.
Conclusion
William Kevin Kelly's contributions to cancer treatment through his innovative patents demonstrate his commitment to improving patient outcomes. His work continues to influence the field of oncology and offers hope for more effective therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile